Follow-Up of Chronic Hepatitis B Carriers: A Cross-Sectional Descriptive-Analytical Study
Journal Title: Modern Care Journal - Year 2017, Vol 14, Issue 1
Abstract
Background: Hepatitis B is a serious liver infection and one of the 5 leading causes of death around the world. Chronic hepatitis B has a variant natural history. Around one-third of patients with chronic hepatitis may eventually develop cirrhosis or hepatocellular carcinoma. The aim of this study was to follow-up chronic hepatitis B carriers. Methods: This cross-sectional descriptive-analytical study was done on 235 chronic hepatitis B carriers, who referred to an infectious disease and tropical medicine clinic, in Birjand, Iran. All chronic hepatitis B carriers, who had referred to the study settings from 2005 to 2013, were approached. Data were entered in the SPSS software (v. 21.0) and analyzed via the Chi-square and the Fisher’s exact tests at a significance level of less than 0.5. Results: The majority of participants were male (132 cases, 56.2%) and married (193 cases, 82.1%) and were aged 33.3 ± 0.7. The follow-up mean time was 5 years with a range of 3 to 9 years. During this follow-up period, 10 individuals (4%) experienced seroconversion from hepatitis B surface antigen (HBsAg) positivity to negativity, 35 (15%) developed active hepatitis, 8 (3.5%) developed cirrhosis, and 2 (1%) developed liver cancer. The remaining 180 participants (76.5%) had inactive hepatitis. Among participants, 45 (19%) were hepatitis B e antigen-positive, 24.5% of whom experienced positivity to negativity seroconversion. Conclusions: Most chronic hepatitis B carriers are primarily asymptomatic. However, 15% developed serious liver disease over time. Therefore, careful lifelong follow-up assessments are needed for early diagnosis and prevention.
Authors and Affiliations
Tahereh Darvishpoor Kakhki, Bita Bigari, Ghodsiyeh Azarkar, Masood Ziaee
Keywords
Related Articles
- EP ID EP292695
- DOI 10.5812/modernc.64726
- Views 132
- Downloads 0
The Prevalence and Risk Factors of Type II Diabetes Mellitus Among Patients with Hepatitis B Virus: A Descriptive Correlational Study
Background: There are 350 million carriers of hepatitis B virus (HBV) around the world. HBV can be associated with type II diabetes mellitus. The aim of this study was to evaluate the prevalence and risk factors for type...
The Angiogenetic Effect of Resveratrol on Dermal Wound Healing in Balb/C Mice
Background: Angiogenesis has a basic role in wound healing. Vascular endothelial growth factor (VEGF) is considered as the most efficient signal that stimulates angiogenesis in wounds. Resveratrol as a natural polyphenol...
The Prevalence of Group B streptococcus Rectovaginal Colonization and Antimicrobial Susceptibility Pattern Among Pregnant Women: A Descriptive-Analytical Study
Background and Aim: Neonatal infections are significantly correlated with maternal rectovaginal colonization with group B streptococcus during pregnancy. Therefore, screening programs are needed for identifying and treat...
Comparing the Prevalence of Hepatitis B Virus Infection in Stationary and Mobile Blood Donation Centers: A Cross-Sectional Descriptive Study
Background and Aim: Blood transfusion can save a million lives. Nonetheless, every recipient is at risk for transfusion-transmissible infection, chiefly hepatitis B infection. The aim of this study was to compare station...
The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, Iran
Background: The presence of HBV DNA in the absence of hepatitis B surface antigen (HBsAg) in the serum of patients is called occult HBV infection (OBI). Because of the risk of hepatitis B transmission, OBI is an importan...